Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis (Q38317550)

2 September 2017

1 reference

title

Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis (English)

1 reference

2 September 2017

Fabrizio Montecucco

4

0 references

author name string

Analina R da Silva

1

1 reference

2 September 2017

Rodrigo A Fraga-Silva

2

1 reference

2 September 2017

Nikolaos Stergiopulos

3

1 reference

2 September 2017

François Mach

5

1 reference

2 September 2017

28 January 2015

1 reference

European Journal of Clinical Investigation

2 September 2017

1 reference

2 September 2017

45

1 reference

2 September 2017

3

1 reference

2 September 2017

274-287

1 reference

Classification of myocardial infarction and unstable angina: a re-assessment

2 September 2017

1 reference

The definitions of acute coronary syndrome, myocardial infarction, and unstable angina

21 January 2018

1 reference

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

21 January 2018

1 reference

Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population

21 January 2018

1 reference

A memorial to Robert Tiegerstedt: the centennial of renin discovery

21 January 2018

1 reference

Recent advances in angiotensin II signaling

21 January 2018

1 reference

Biological functions of angiotensin and its receptors

21 January 2018

1 reference

Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism

21 January 2018

1 reference

Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways.

21 January 2018

1 reference

Aldosterone induces C-reactive protein expression via MR-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells

21 January 2018

1 reference

The angiotensin II type 2 receptor in cardiovascular disease

21 January 2018

1 reference

Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease

21 January 2018

1 reference

Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications

21 January 2018

1 reference

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system.

21 January 2018

1 reference

Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide

21 January 2018

1 reference

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

21 January 2018

1 reference

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.

21 January 2018

1 reference

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.

21 January 2018

1 reference

Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review

21 January 2018

1 reference

Mass-spectrometric identification of a novel angiotensin peptide in human plasma.

21 January 2018

1 reference

Discovery and characterization of alamandine: a novel component of the renin-angiotensin system

21 January 2018

1 reference

Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease

21 January 2018

1 reference

The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes

21 January 2018

1 reference

Pathologic assessment of the vulnerable human coronary plaque

21 January 2018

1 reference

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

21 January 2018

1 reference

Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress

21 January 2018

1 reference

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

21 January 2018

1 reference

Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs

21 January 2018

1 reference

Local proliferation dominates lesional macrophage accumulation in atherosclerosis

21 January 2018

1 reference

Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.

21 January 2018

1 reference

Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis

21 January 2018

1 reference

Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages

21 January 2018

1 reference

Role of renin-angiotensin system in activation of macrophages by modified lipoproteins

21 January 2018

1 reference

Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases

21 January 2018

1 reference

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

21 January 2018

1 reference

Inflammation and atherosclerosis

21 January 2018

1 reference

Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism.

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors

21 January 2018

1 reference

Angiotensin-converting enzyme regulates bradykinin receptor gene expression

21 January 2018

1 reference

Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress.

21 January 2018

1 reference

Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein E-deficient mice.

21 January 2018

1 reference

Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells

21 January 2018

1 reference

Impact of matrix metalloproteinases on atherosclerosis

21 January 2018

1 reference

Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype

21 January 2018

1 reference

Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats

21 January 2018

1 reference

Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.

21 January 2018

1 reference

Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity

21 January 2018

1 reference

Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques

21 January 2018

1 reference

Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis.

21 January 2018

1 reference

Role of apoptosis in atherosclerosis and its therapeutic implications

21 January 2018

1 reference

Functional interactions between 7TM receptors in the renin-angiotensin system--dimerization or crosstalk?

21 January 2018

1 reference

Microvascular angiogenesis and the renin-angiotensin system.

21 January 2018

1 reference

Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease.

21 January 2018

1 reference

Tissue factor and cardiovascular disease: quo vadis?

21 January 2018

1 reference

PAI-1 and atherothrombosis

21 January 2018

1 reference

Links between inflammation and thrombogenicity in atherosclerosis

21 January 2018

1 reference

Angiotensin II, tissue factor and the thrombotic paradox of hypertension

21 January 2018

1 reference

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

21 January 2018

1 reference

Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells

21 January 2018

1 reference

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

21 January 2018

1 reference

Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.

21 January 2018

1 reference

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.

21 January 2018

1 reference

Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.

21 January 2018

1 reference

Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells

21 January 2018

1 reference

Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice

21 January 2018

1 reference

Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function

21 January 2018

1 reference

Short-term angiotensin(1-7) receptor MAS stimulation improves endothelial function in normotensive rats

21 January 2018

1 reference

Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function.

21 January 2018

1 reference

Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis.

21 January 2018

1 reference

ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages

21 January 2018

1 reference

Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages.

21 January 2018

1 reference

Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.

21 January 2018

1 reference

Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells

21 January 2018

1 reference

An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect

21 January 2018

1 reference

Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis

21 January 2018

1 reference

Angiotensin converting enzyme 2 and atherosclerosis

21 January 2018

1 reference

Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice

21 January 2018

1 reference

The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies

21 January 2018

1 reference

Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease

21 January 2018

1 reference

Angiotensin II receptor antagonists in acute coronary syndromes

21 January 2018

1 reference

Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene

21 January 2018

1 reference

Renin-angiotensin system and atherothrombotic disease: from genes to treatment

21 January 2018

1 reference

Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke

21 January 2018

1 reference

Effects of ramipril on serum monocyte chemoattractant protein 1, interleukin-18, and interleukin-10 in elderly patients with acute coronary syndrome

21 January 2018

1 reference

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

21 January 2018

1 reference

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

21 January 2018

1 reference

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

21 January 2018

1 reference

The renin-angiotensin-aldosterone system as a target in coronary disease

21 January 2018

1 reference

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

21 January 2018

1 reference

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

21 January 2018

1 reference

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials

21 January 2018

1 reference

A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure

21 January 2018

1 reference

Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure

21 January 2018

1 reference

Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox

21 January 2018

1 reference

Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system

21 January 2018

1 reference

Angiotensin AT2 receptors: cardiovascular hope or hype?

21 January 2018

1 reference

21 January 2018

1 reference

Current role of neprilysin inhibitors in hypertension and heart failure

21 January 2018

1 reference

Angiotensin-neprilysin inhibition versus enalapril in heart failure

21 January 2018

1 reference

Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status

21 January 2018

1 reference

Mechanisms of LDL oxidation

21 January 2018

1 reference

Cathepsin G is associated with atheroma formation in human carotid artery.

21 January 2018

1 reference

Non-ACE pathway-induced angiotensin II production

21 January 2018

1 reference

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

21 January 2018

1 reference

Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.

21 January 2018

1 reference

Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study.

21 January 2018

1 reference

Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives

21 January 2018

1 reference

Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system

21 January 2018

1 reference

Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes

21 January 2018

1 reference

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

21 January 2018

1 reference

Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system

21 January 2018

1 reference

Treatment with Angiotensin-(1–7) reduces inflammation in carotid atherosclerotic plaques

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ECI.12401

1 reference

release_wvn47gse6vekbeexari7tdzbfi

2 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wvn47gse6vekbeexari7tdzbfi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference